Conditions: Esophageal Cancer
Intervention Type: Drug
Intervention Name: Capecitabine
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "Capecitabine" on "Esophageal Cancer".
-
A Phase II Study of Weekly Paclitaxel and Capecitabine in Patients With Metastatic or Recurrent Esophageal Cancer
NCTID: NCT00453323
-
Combined Phase I/II Study of Epirubicin (Pharmorubicin��), Carboplatin (Paraplatin��) and Capecitabine (Xeloda��) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
NCTID: NCT00130936
-
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
NCTID: NCT00848783